Kardium announces US$ 104 million in new financing for innovative Atrial Fibrillation Treatment
Private financing round supported by Fidelity Management & Research Company, T. Rowe Price and Durable Capital Partners
Private financing round supported by Fidelity Management & Research Company, T. Rowe Price and Durable Capital Partners
This strategic decision will unlock significant value for our scientific and industrial products business
Scientific consensus is that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer and GSK will continue to vigorously defend itself against all claims
Profit Before Tax is Rs. 220 crore, registering a commendable 64% growth
Keimed is a leading wholesale pharma distribution with industry leading operating metrics
Commercial terms include research funding and milestones and/or royalty payments to Evotec based on the success of the program
The company plans to add 1700 beds by FY27 through the organic route
The MDC business produces components for medical device manufacturers globally with a focus on precious metal alloys and nitinol
Subscribe To Our Newsletter & Stay Updated